RSS   Newsletter   Contact   Advertise with us
Post Online Media

Oramed Pharmaceuticals appoints Ronald Law as CSO

OramedOramed Pharmaceuticals, a pharmaceutical company, announced the appointment of Ronald Law to the newly created position of chief strategy officer.

Dr. Law has over 25 years of academic and pharmaceutical industry experience in diabetes, cardiovascular disease, and obesity.

During his industry career at Takeda Pharmaceuticals, Dr. Law served in a variety of leadership and strategic roles spanning US Medical Affairs, Global Medical Affairs, Corporate Strategic Planning, Global Scientific Affairs and Intelligence, and R&D External Innovation.

Prior to joining Takeda, Dr. Law was an Associate Professor of Medicine in the Endocrinology Division, UCLA School of Medicine.

Dr. Law received a PhD in Molecular Biology from UCLA and a JD from the Whittier College School of Law.

He is a member of the American Diabetes Association and the American Heart Association.


    More inside POST

    We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

    Allow Cookies Privacy Policy